Is there "seasonal" variation in height velocity in children treated with growth hormone? Data from the National Cooperative Growth Study
Related Experiment Video
Updated: May 14, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Dorothy I Shulman1, James Frane, Barbara Lippe
1Department of Pediatrics, University of South Florida Morsani College of Medicine, MDC 62, , 12901 Bruce B, Downs Blvd,,Tampa, FL, 33612, USA. dshulman@health.usf.edu.
Insights
Children on growth hormone (GH) therapy show seasonal growth variations linked to daylight hours. This effect is most pronounced in the first year of treatment and diminishes over time.
Area of Science:
- Pediatric Endocrinology
- Chronobiology
- Growth Hormone Therapy
Background:
- Childhood growth rates exhibit seasonal patterns.
- Limited data exist on seasonal variability during growth hormone (GH) therapy.
- No studies have analyzed growth rates in relation to daylight hours.
Purpose of the Study:
- To investigate the correlation between daylight hours and growth rate in children receiving recombinant human growth hormone (rhGH) therapy.
- To analyze seasonal variations in height velocity (HV) among prepubertal children on rhGH therapy.
Main Methods:
- Analysis of 11,587 three-month intervals from 2277 prepubertal children in the National Cooperative Growth Study (NCGS) database.
- Correlation of height velocity (HV) with the average number of daylight hours, considering latitude, age, GH dose, and other patient factors.
- Inclusion of children naive to rhGH therapy from 31 US study centers.
Main Results:
- Height velocity (HV) significantly correlated with daylight hours, showing greater growth in summer than winter.
- The seasonal effect was most pronounced in the first year of rhGH therapy (0.146 cm/yr/daylight hour) and persisted in subsequent years (0.121 cm/yr/daylight hr).
- The difference in growth rate between summer and winter increased with distance from the equator, but overall annual growth rates were similar across North American latitudes.
Conclusions:
- Seasonal growth variation in children on rhGH therapy is linked to the number of daylight hours.
- This seasonal effect is modest, most significant during the initial year of treatment, and its physiological mechanism requires further investigation.
- Annual growth rates are comparable across different latitudes within the US, suggesting daylight exposure is a key factor.
Background:
Growth rate In children is reported to have seasonal variability. There are fewer published data regarding seasonal variability while on growth hormone (GH) therapy, and none analyzing growth rate with respect to number of daylight hours.
Methods:
We analyzed 11,587 3-month intervals in 2277 prepubertal children (boys ages 3-14 years, girls ages 3-12 years) with idiopathic GH deficiency from the National Cooperative Growth Study (NCGS) database. All were naive to recombinant human GH (rhGH) therapy. Data were submitted from 31 US study centers. Seasonal variation in height velocity (HV) was assumed to be associated with the average number of daylight hours during the interval of time over which HV was computed. Number of daylight hours was determined from the date of the measurement and the latitude of the study center. Other independent variables evaluated included: height standard deviation score (SDS) at the beginning of the interval, chronologic age at the beginning of the interval, time from the start of rhGH treatment to the middle of the interval, month of the year, body mass index SDS at the beginning of the interval, rhGH dose/kg, mother's height SDS, father's height SDS, and log base 10 of the maximum stimulated GH concentration.
Results:
All variables examined, except month of the year, correlated significantly with interval HV. There was significant "seasonal" variability at all latitudes, with summer annualized HV being greater than winter HV. This difference was greatest in the first year of therapy (0.146 cm/yr/daylight hour; P < 0.0001) but persisted in subsequent years (0.121 cm/yr/daylight hr; P < 0.0001). The difference increased with distance from the equator. Growth rate over the year was not different among the latitudes reflected in this North American study.
Conclusions:
There is "seasonal" variation in growth of children on rhGH therapy that correlates with number of daylight hours. The effect is modest and is greatest in the first year of therapy. Annual growth rate appears to be equal in children among latitudes covered by the US consistent with exposure to an equal number of daylight hours over the year. The physiologic mechanism behind this seasonal variation is not yet understood.
Related Concept Videos
Nature and Nurture
Variation: Normal Distribution, Range, and Standard Deviation
Polygenic Traits
Signs of Puberty
Heritability
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

